Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1978 Jan;40(1):91–94. doi: 10.1136/hrt.40.1.91

The prostaglandin challenge. Test to unmask obstructed total anomalous pulmonary venous connections in asplenia syndrome.

R M Freedom, P M Olley, F Coceani, R D Rowe
PMCID: PMC481981  PMID: 626671

Abstract

The patient with complex congenital heart disease, severe pulmonary outflow obstruction, and visceral heterotaxia, may have 'silent' obstruction of the pulmonary venous return. Severe reduction of pulmonary blood flow secondary to pulmonary stenosis or atresia in such patients may prevent the usual radiographic appearance of pulmonary oedema. If such obstructed anomalous pulmonary venous connections are not diagnosed before operation, construction of a systemic to pulmonary artery anastomosis will unmask the obstruction, usually resulting in pulmonary oedema and death. We have recently 'challenged' a neonate with dextrocardia, vesceral heterotaxia, presumed asplenia, and complex congenital heart disease including pulmonary atresia, with an infusion of prostaglandin E1 to increase pulmonary blood flow via his ductus arteriosus. This resulted in severe pulmonary oedema which partially resolved after the infusion was discontinued. This was interpreted as consistent with obstructed total anomalous pulmonary venous return. This was confirmed at necropsy. Thus, the infusion of prostaglandin E1 before operation in the patient with asplenia or similar cardiac disease may be of aid in unmasking 'silent' obstructions of the pulmonary veins, and is of obvious value in the preoperative assessment of such patients.

Full text

PDF
91

Images in this article

92Image
on p.92
92Image
on p.92
92Image
on p.92

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ando F., Shirotani H., Kawai J., Kanzaki Y., Setsuie N. Successful total repair of complicated cardiac anomalies with asplenia syndrome. J Thorac Cardiovasc Surg. 1976 Jul;72(1):33–38. [PubMed] [Google Scholar]
  2. Coceani F., Olley P. M., Bodach E. Lamb ductus arteriosus: effect of prostaglandin synthesis inhibitors on the muscle tone and the response to prostaglandin E2. Prostaglandins. 1975 Feb;9(2):299–308. doi: 10.1016/0090-6980(75)90034-9. [DOI] [PubMed] [Google Scholar]
  3. Coceani F., Olley P. M. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol. 1973 Mar;51(3):220–225. doi: 10.1139/y73-031. [DOI] [PubMed] [Google Scholar]
  4. Delisle G., Ando M., Calder A. L., Zuberbuhler J. R., Rochenmacher S., Alday L. E., Mangini O., Van Praagh S., Van Praagh R. Total anomalous pulmonary venous connection: Report of 93 autopsied cases with emphasis on diagnostic and surgical considerations. Am Heart J. 1976 Jan;91(1):99–122. doi: 10.1016/s0002-8703(76)80440-1. [DOI] [PubMed] [Google Scholar]
  5. Esterly J. R., Oppenheimer E. H. Lymphangiectasis and other pulmonary lesions in the asplenia syndrome. Arch Pathol. 1970 Dec;90(6):553–560. [PubMed] [Google Scholar]
  6. Gersony W. M. Editorial: Obstruction to pulmonary venous return obscured by decreased pulmonary blood flow. Chest. 1973 Sep;64(3):283–283. doi: 10.1378/chest.64.3.283. [DOI] [PubMed] [Google Scholar]
  7. LUCAS R. V., Jr, NEUFELD H. N., LESTER R. G., EDWARDS J. E. The symmetrical liver as a roentgen sign of asplenia. Circulation. 1962 Jun;25:973–975. doi: 10.1161/01.cir.25.6.973. [DOI] [PubMed] [Google Scholar]
  8. Muster A. J., Paul M. H., Nikaidoh H. Tetralogy of Fallot associated with total anomalous pulmonary venous drainage. Chest. 1973 Sep;64(3):323–326. doi: 10.1378/chest.64.3.323. [DOI] [PubMed] [Google Scholar]
  9. Olley P. M., Bodach E., Heaton J., Coceani F. Further evidence implicating E-type prostaglandins in the patency of the lamb ductus arteriosus. Eur J Pharmacol. 1975 Nov;34(1):247–250. doi: 10.1016/0014-2999(75)90248-4. [DOI] [PubMed] [Google Scholar]
  10. Olley P. M., Coceani F., Bodach E. E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations. Circulation. 1976 Apr;53(4):728–731. doi: 10.1161/01.cir.53.4.728. [DOI] [PubMed] [Google Scholar]
  11. PUTSCHAR W. G., MANION W. C. Congenital absence of the spleen and associated anomalies. Am J Clin Pathol. 1956 May;26(5):429–470. doi: 10.1093/ajcp/26.5.429. [DOI] [PubMed] [Google Scholar]
  12. ROBERTS W. C., BERRY W. B., MORROW A. G. The significance of asplenia in the recognition of inoperable congenital heart disease. Circulation. 1962 Dec;26:1251–1253. doi: 10.1161/01.cir.26.6.1251. [DOI] [PubMed] [Google Scholar]
  13. RUTTENBERG H. D., NEUFELD H. N., LUCAS R. V., Jr, CAREY L. S., ADAMS P., Jr, ANDERSON R. C., EDWARDS J. E. SYNDROME OF CONGENITAL CARDIAC DISEASE WITH ASPLENIA. DISTINCTION FROM OTHER FORMS OF CONGENITAL CYANOTIC CARDIAC DISEASE. Am J Cardiol. 1964 Mar;13:387–406. doi: 10.1016/0002-9149(64)90454-0. [DOI] [PubMed] [Google Scholar]
  14. Rose V., Izukawa T., Moës C. A. Syndromes of asplenia and polysplenia. A review of cardiac and non-cardiac malformations in 60 cases withspecial reference to diagnosis and prognosis. Br Heart J. 1975 Aug;37(8):840–852. doi: 10.1136/hrt.37.8.840. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES